Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
News
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
Cheng Yi
Company notice
Company news
Media coverage
2020,02,20
Zheng Cheng Yi Pharmaceutical 100 Person Disinfection Exercise
2020,02,18
Cheng Yi Pharmaceutical Comprehensive Epidemic Prevention
2020,02,16
Cheng Yi Pharmaceutical Resumption of Work and Epidemic Prevention
2020,02,10
Cheng Yi Pharmaceutical Donates Supplies to Zhejiang Charity Federation
2020,02,05
Ribavirin was selected into the diagnosis and treatment scheme of COVID-19
2020,02,05
District leaders sent congratulatory letters to Cheng Yi Pharmaceutical
2020,01,18
The book "From the Sea to Shanghai" was published
2019,12,25
The Legendary Life of Yan Yiyi, the Leader of Cheng Yi Pharmaceutical
2019,12,10
Cheng Yi Pharmaceutical always adheres to the driving force of innovation
2019,11,04
Be a good "liaison" and convey a "good voice"
2019,10,21
Sincere Pharmaceutical won the "Best Growth Potential Listed Company" award
2019,10,17
Full coverage of 'Party managed talents'
<
1
...
7
8
9
...
16
>
Contact Us
view more